Private equity's increasing presence in the UK vet sector is raising concerns over profit versus care, with critics arguing that this financing model prioritises short-term gains over the long-term health of businesses. The industry, however, counters that private equity brings vital capital, expertise, and efficiency to companies, particularly those in fragmented markets like the veterinary sector. A notable example is the estimated £3 billion worth of investment from private equity firms in UK vets since 2010, which has seen numerous small practices consolidate into larger groups.
A contentious issue is the use of debt, or 'leverage', to finance these acquisitions. Critics suggest this can burden acquired companies with significant financial obligations, potentially compromising their ability to provide high-quality care. However, UK Private Capital asserts that lenders conduct rigorous due diligence, only supporting transactions deemed sustainable, and that private equity firms' success is intrinsically linked to building stronger, more valuable businesses over time.
Concerns also centre on cost-cutting measures and profit maximisation. While private equity firms argue they professionalise businesses through capital and expertise, critics worry about potential negative side-effects on staff and service quality. The industry highlights that 'roll-ups' can bring strategic benefits, improving capabilities and maintaining competition within the market.
The ownership model itself is also under scrutiny, with some arguing that private equity prioritises short-term financial gains over the long-term health of businesses. UK Private Capital disputes this, stating that private equity investment is inherently long-term, with an average holding period exceeding six years. They emphasise that creating growing companies with strong growth potential is fundamental to their strategy.
Regulators will need to ensure standards and choice are protected amid these changes. In the veterinary sector specifically, investment from private equity has been highlighted as a means to achieve efficiencies and invest in new medical technology. However, Dr David Reader, a senior lecturer in law at the University of Glasgow, also notes that this trend may lead to reduced competition and decreased accessibility for rural or disadvantaged communities.